BTG3
From Wikipedia, the free encyclopedia
BTG family, member 3
|
|||||||||||
Identifiers | |||||||||||
Symbol(s) | BTG3; ANA; MGC8928; TOB5; TOB55; TOFA | ||||||||||
External IDs | OMIM: 605674 MGI: 109532 HomoloGene: 4953 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 10950 | 12228 | |||||||||
Ensembl | ENSG00000154640 | n/a | |||||||||
Uniprot | Q14201 | n/a | |||||||||
Refseq | NM_006806 (mRNA) NP_006797 (protein) |
XM_622699 (mRNA) XP_622699 (protein) |
|||||||||
Location | Chr 21: 17.89 - 17.91 Mb | n/a | |||||||||
Pubmed search | [1] | [2] |
BTG family, member 3, also known as BTG3, is a human gene.[1]
The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein might play a role in neurogenesis in the central nervous system.[1]
[edit] References
[edit] Further reading
- Matsuda S, Rouault J, Magaud J, Berthet C (2001). "In search of a function for the TIS21/PC3/BTG1/TOB family.". FEBS Lett. 497 (2-3): 67-72. PMID 11377414.
- Guéhenneux F, Duret L, Callanan MB, et al. (1997). "Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle.". Leukemia 11 (3): 370-5. PMID 9067576.
- Yoshida Y, Matsuda S, Ikematsu N, et al. (1998). "ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system.". Oncogene 16 (20): 2687-93. doi: . PMID 9632145.
- Hattori M, Fujiyama A, Taylor TD, et al. (2000). "The DNA sequence of human chromosome 21.". Nature 405 (6784): 311-9. doi: . PMID 10830953.
- Birot A, Duret L, Bartholin L, et al. (2000). "Identification and molecular analysis of BANP.". Gene 253 (2): 189-96. PMID 10940556.
- Yoshida Y, Hosoda E, Nakamura T, Yamamoto T (2001). "Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex.". Jpn. J. Cancer Res. 92 (6): 592-6. PMID 11429045.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173-8. doi: . PMID 16189514.
- Lim J, Hao T, Shaw C, et al. (2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.". Cell 125 (4): 801-14. doi: . PMID 16713569.
- Ou YH, Chung PH, Hsu FF, et al. (2007). "The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.". EMBO J. 26 (17): 3968-80. doi: . PMID 17690688.